25B-NBOMe (hydrochloride)

Confirm delete?

Zoom

Cat No: 12047

Biochemicals - Analytical Standards

2C-B is a hallucinogenic designer drug which potently activates the serotonin receptor 5-HT2C (pEC50 = 6.8 for arachidonic acid release).{20772} 25B-NBOMe is a derivative of 2C-B, characterized by the addition of a benzyl-methoxy (BOMe) group to the am...

This article is not for sale online.
Contact us for more information about this article.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

                                            Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.
                    

                        Special Advice: Reference Materials RMs and Certified Reference Materials CRMs are dispatched directly to the end-user in accordance with ISO requirements. Please check regulation status before ordering; additionel fees can apply. 
                    

Synonyms:

4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine, monohydrochloride

Correlated keywords:

1026511-90-9 forensics designer drugs phenethylamines serotonins receptors agonists hallucinogen 25BNOMe HCl 25B NBOMes benzyl-methoxy BOMe amines derivatives 2C-D 2CD 2Cs D 2C-B 2CB B 5-HT2A HTs hHT2A 5-HT Cimbi-36 Cimbi36 Cimbi analytical references standards ISO00132 RM ISO 00132 ISO132 ISO 132 2,5b-nbome

Product Overview:
2C-B is a hallucinogenic designer drug which potently activates the serotonin receptor 5-HT2C (pEC50 = 6.8 for arachidonic acid release).{20772} 25B-NBOMe is a derivative of 2C-B, characterized by the addition of a benzyl-methoxy (BOMe) group to the amine. This N-(2-methoxybenzyl) addition significantly increases the affinity (Ki = 1.01 nM) and activity (ED50 = 0.51 nM) at the serotonin receptor 5-HT2A.{21331} This product is intended for research and forensic applications.

Size	1 mg
Shipping	dry ice
CAS Number	1539266-15-3
Molecular Formula	C₁₈H₂₂BrNO₃ • HCl
SMILES	BrC1=C(OC)C=C(CCNCC2=C(OC)C=CC=C2)C(OC)=C1.Cl
Molecular Weight	416,7
Formulation	A neat solid
Purity	≥98%
Custom Code	3822.19
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.